Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

 
You are here: Home / Sites / Mount Sinai Hospital / Diamandis, Eleftherios P.

Diamandis, Eleftherios P. (Ph.D.)

PI, Mount Sinai Hospital, 416-586-8443

Contact Information

Email: mailto:Eleftherios.Diamandis@sinaihealthsystem.ca
Fax: 416-586-8628
EDRN Associate Member

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

Protocol Name Biomarkers Datasets
The Early Detection Research Network: Biomarker Reference Laboratories 0 0
Validation of Early Detection Ovarian Cancer Biomarkers (Team Project) 149 0

Closed Protocols

Protocol Name Biomarkers Datasets
BRSCW Reference Set Application: Eleftherios Diamandis - Mt Sinai (2006) 0 0
Intergrated Systems Biology Approach for Ovarian Cancer Biomarker Discovery 13 0
Prostate Rapid Reference Set Application: Eleftherios Diamandis - Mt Sinai (2006) 4 1
Lung Reference Set A Application: Lee Goodglick/ Eleftherios Diamandis- UCLA/MSH (2009) 0 0
Prostate Rapid Pre-Validation Set 6 0

Publications

Publication Name PubMed ID Journal
CUB and zona pellucida-like domain-containing protein 1 (CUZD1): a novel serological biomarker for ovarian cancer. 22985796 Clin. Biochem.
Cancer biomarkers: can we turn recent failures into success? 20705936 J. Natl. Cancer Inst.
A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy. 18056174 Clin. Cancer Res.

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.

Addresses

Dept. of Pathology and Laboratory Medicine, 60 Murray Street, 6th Fl.
Mount Sinai Hospital

To update addresses, please visit the Data Management and Coordinating Center.

Announcement 03/14/2018
Thank you to everyone to made the 10th EDRN Scientific Workshop a success. The next event is the 33rd EDRN Steering Committee Meeting from September 5-6, 2018 in Boston, MA. Details will be available soon.


Three new FOAs on the Human Tumor Atlas and associated with the Cancer Moonshot Initiative have been released. Please click here for more information.
Announcement 10/23/2017

Three new FOAs on the Human Tumor Atlas and associated with the Cancer Moonshot Initiative have been released. Please click here for more information.
EDRN Founder Honored

Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.